Compare ARK Genomic Revolution ETF (ARKG) vs BlackBerry Limited (BB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs BlackBerry Limited — how do they compare? ARK Genomic Revolution ETF trades at $41.3, while BlackBerry Limited trades at $10.88 (market cap $6.42B). Which is the better fit depends on your goals.
| ARKG | BB | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $12.81 |
52-Week Low | $23.09 | $3.15 |
Market Cap | — | $6.42B |
Enterprise Value | — | $6.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BlackBerry (BB) trades at $10.97, down 4.02% today, with a bullish technical outlook supported by moving averages. The company shows improving fundamentals with three consecutive quarterly EPS beats and projected profitability in 2026. Recent news highlights strong QNX growth in automotive and robotics sectors, though valuation metrics remain elevated with P/E at 109.7 and P/S at 11.26.
The outlook is cautiously optimistic as BlackBerry's turnaround gains traction with improved cash flow and QNX momentum. Key risks include execution challenges amid rich valuation and competitive pressures. Analyst consensus leans neutral with 85.7% hold ratings and $10.50 price target, suggesting limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About BlackBerry Limited
BlackBerry Limited provides intelligent security software solutions. The Company offers artificial intelligence and machine learning for cybersecurity, safety, and data privacy solutions, as well as endpoint security and management, encryption, and embedded systems. BlackBerry serves governments and enterprise sectors worldwide.
Read more on BB →
